Trial Profile
Prospective observation study of Sitagliptin in patients with type 2 diabetes
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SCRUM Study
- 03 Jun 2016 New trial record